Opportunities and resources for editorial staff

Who We Are

The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. 

The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. 

For interview and media registration requests, please contact


Active Media Coverage Opportunities


ASGCT Insights Week

October 16-20, 2023 | Virtual

For editorial staff: FREE access. Contact

Join CGT experts in October for five virtual, two-hour sessions on:

  • Revisiting ASGCT's Annual Meeting abstracts

  • Risk assessment of lentiviral & AAV gene therapy vectors

  • Risk assessment of gene-editing technologies

  • Treating genetic diseases prior to birth

  • Innate immune responses

View the agenda

Policy Summit 

September 18-19, 2023 | On Demand Until Oct. 23, 2023

For editorial staff: FREE on-demand access for 30 days after the event. Contact

The ASGCT policy and advocacy leaders continuously liaise with major health policy stakeholders, such as FDA, NIH, and Congress. With the Society's advocacy team an established player in the field of gene and cell therapy, our Policy Summit is the opportunity to see top policy and industry leaders come together.

Your complimentary registration would provide access to diverse perspectives on regulatory, legislative, and payment policies that impact gene and cell therapy development.

Speakers include Nicole Verdun, MD (Director of FDA CBER Office of Therapeutic Products (OTP)); Renee Wegrzyn, PhD (Director of the Advanced Research Projects Agency for Health, ARPA-H); and Laura McWright (Center for Medicare & Medicaid Innovation). They'll speak on biomedical innovation, gene therapy access, setting development standards, the Bespoke Gene Therapy Consortium, and more.

View the agenda

Focus Areas

Gene, Cell, & RNA Therapy Landscape Report

Created in partnership with Informa Pharma Intelligence, this is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

Learn about: 

  • Top research areas
  • Statistics on therapies in the pipeline
  • Latest clinical trials and approvals updates

View all landscape reports

Show Answer
Policy & Advocacy Work

ASGCT's leaders are experts in: 

The Society advocates for its members' and patients' needs through legislative meetings, liaising with the FDA, and publishing policy statements and letters

Please contact with any interview requests. 

Read policy statements and research

Show Answer
Patient Education Resources

ASGCT's award-winning free Patient Education site provides scientific, reliable information for patients and the public. Expert members review and update all content. 

View clear and accessible resources on topics such as gene therapy 101 and disease treatments.

Access educational resources

Show Answer


ASGCT Policy Summit

Watch on demand through Oct. 23!

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.